First Time Loading...
S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 161.3 HKD -2.83%
Updated: May 29, 2024

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Selling, General & Administrative

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Selling, General & Administrative Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Selling, General & Administrative
-¥201.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Selling, General & Administrative
-¥10.9B
CAGR 3-Years
-38%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Selling, General & Administrative
-¥3.9B
CAGR 3-Years
-29%
CAGR 5-Years
-61%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Selling, General & Administrative
-¥1.9B
CAGR 3-Years
-32%
CAGR 5-Years
-38%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Selling, General & Administrative
-¥3.8B
CAGR 3-Years
-32%
CAGR 5-Years
-30%
CAGR 10-Years
-29%
Imeik Technology Development Co Ltd
SZSE:300896
Selling, General & Administrative
-¥281.4m
CAGR 3-Years
-32%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-201.4m CNY

Based on the financial report for Dec 31, 2023, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Selling, General & Administrative amounts to -201.4m CNY.

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 1Y
-147%

Over the last year, the Selling, General & Administrative growth was -147%.